Pink Sheet Podcast: New Drug Submissions Lag, FDA EUAs On The Way, BsUFA Revenue Misses Estimates

Pink Sheet reporter and editors discuss the lower new drug submission rate in 2020, another EUA for a potential coronavirus treatment, and the biosimilar user fee program missing revenue estimates again.